|
|
|
|
|
|
5 Dangers Of An Insecure API Supply Chain | e-book | Pfizer CentreOne | See how diversifying API supply chain beyond multiple suppliers through geographic spread and raw material origins can promote uninterrupted medicine supply and patient access. |
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Consider these two questions: How do we select a CDMO? How do we select a facility? The second of these should carry as much weight as the first, but unfortunately often does not. Chief Editor Louis Garguilo thinks that should change. He turns to Eli Lilly's ISPE Award Winning facility, and Lorraine O'Shea, Associate Vice President and Plant Manager at Lilly Kinsale, to make the case. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
Using Synthesis And Route Design Technology To Approach API Complexity | Article | By Dr. Ryan Littich, Lonza and Dr. Juergen Swienty-Busch, Elsevier Information Systems | Leveraging computer-aided synthesis design technology and route scouting in the early stages of development can aid you in designing an efficient and cost-effective path to API manufacturing. |
|
|
|
|
|
|
|
| Join Outsourced Pharma Online on September 3rd at 2pm ET for a virtual panel discussion on overcoming difficulties outsourcing development and manufacturing, how does a biopharma organization (of any size) handle a multi-CDMO coordination. Registration is free for this digital event. |
|
|
|
Regulatory Starting Materials (RSMs) — India | Pharma Expanse | The Pharma Expanse network currently spans across 9 manufacturing sites in 5 countries and can support discovery, preclinical, clinical and commercial programs for New Chemical Entities (NCEs). |
|
|
Pharmaceutical Solutions | Grace Fine Chemical Manufacturing Services | Explore a wide breadth of services, including product development, analytical method development, project management, and custom chemical synthesis. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
